Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134691) titled 'A Prospective, Single-Arm, Exploratory Clinical Study of QL1706 Combined with Chemotherapy with or without Bevacizumab for Recurrent/Metastatic Cervical Cancer Progressed after Immunotherapy' on Oct. 19.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Sun Yat-sen University Cancer Center (Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Sun Yat-sen University Cancer Institute)
Condition:
Pathologically or radiologically confirmed recurrent or metastatic cervical cancer, unsuitable for radical treatments such as surgery or radiotherapy
radiologically confirmed and treated wit...